Mode
Text Size
Log in / Sign up

Overweight

33 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Overweight

140 trials tracked for Overweight: 42 in phase 3 or 4 and 24 with published results. The most-cited published study has 6045 citations.

140Trials tracked
42Phase 3 & 4
0Recruiting
24With published results
Phase distribution
Phase 4 11 Phase 3 31 Phase 2 15 Phase 1 5 Other / NA 78
  1. Phase 4 The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS Completed · 6,045 cited
  2. Phase 3 Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity Completed · 4,362 cited
  3. Phase 3 STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesity Completed · 1,279 cited
  4. Phase 3 Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity Completed · 1,262 cited
  5. Phase 3 Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle Program Completed · 989 cited
  6. Phase 3 Research Study to Investigate How Well Semaglutide Works Compared to Liraglutide in People Living With Overweight or Obesity Completed · 861 cited
Show 44 more trials
  1. Phase 3 Two-year Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity Completed · 764 cited
  2. Phase 3 A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Who Have Obesity or Are Overweight Completed · 664 cited
  3. Phase 3 A Research Study on How Well Semaglutide Works in Adolescents With Overweight or Obesity Completed · 618 cited
  4. Phase 3 A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight With Weight Related Comorbidities Completed · 399 cited
  5. Phase 3 Research Study to Investigate How Well Semaglutide Tablets Taken Once Daily Work in People Who Are Overweight or Living With Obesity (OASIS 1) Completed · 371 cited
  6. Phase 3 Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized Approach Completed · 264 cited
  7. Phase 4 A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors Completed · 263 cited
  8. Phase 4 Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes Completed · 242 cited
  9. Phase 3 Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorders (ASD) Completed · 118 cited
  10. Phase 3 Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity. Completed · 111 cited
  11. Phase 3 A Study of Tirzepatide (LY3298176) in Chinese Participants Without Type 2 Diabetes Who Have Obesity or Overweight (SURMOUNT-CN) Completed · 104 cited
  12. Phase 3 Targeting Inflammation Using Salsalate in CardioVascular Disease Completed · 61 cited
  13. Phase 3 Research Study Looking at How Well Semaglutide Tablets Taken Once Daily Work in People Who Have a Body Weight Above the Healthy Range Completed · 60 cited
  14. Phase 3 A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight for the Maintenance of Weight Loss Completed · 14 cited
  15. Phase 3 Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management Completed · 13 cited
  16. Phase 4 Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc Completed · 3 cited
  17. Phase 3 A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program Completed · 3 cited
  18. Phase 3 A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight Completed · 1 cited
  19. Phase 4 Mechanisms of Weight Loss With SGLT2 Inhibition Completed
  20. Phase 4 Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers Completed
  21. Phase 4 Angiotensin II Blockade and Inflammation in Obesity Completed
  22. Phase 4 Effect of Calcium + Vitamin D Supplementation on Weight Management in Very-low Calcium Consumers Completed
  23. Phase 4 Exercise and Phytoestrogens: Effect on Factors Predisposing to Cardiovascular Disease(CVD) in Postmenopausal Women Completed
  24. Phase 4 Effect of Orlistat in Body Composition Completed
  25. Phase 4 Litramine in Weight Maintenance Completed
  26. Phase 3 Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function Completed
  27. Phase 3 A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range Completed
  28. Phase 3 Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension Completed
  29. Phase 3 A Safety and Efficacy Study of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Participating in an Intensive Behavior Modification Program Completed
  30. Phase 3 Effect of Vitamin D on Metabolic Profile in Overweight or Obese Women Completed
  31. Phase 3 A Study of the Safety and Efficacy of Two Doses of Naltrexone SR/Bupropion SR and Placebo in Overweight and Obese Subjects Completed
  32. Phase 3 Method-of-Use Study Assessing the Effect of Naltrexone Sustained Release (SR)/ Bupropion SR on Body Weight and Cardiovascular Risk Factors in Overweight and Obese Subjects Completed
  33. Phase 3 A Safety and Efficacy Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects Completed
  34. Phase 3 Efficacy and Safety of IQP-VV-102 in Weight Management Completed
  35. Phase 3 Efficacy and Safety of Zenoctil in Reducing Body Weight Completed
  36. Phase 3 A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes Completed
  37. Phase 2 Trial of Leptin Administration After Roux-en-Y Gastric Bypass Completed
  38. Phase 2 A Study of LY3437943 in Participants Who Have Obesity or Are Overweight Completed
  39. Phase 2 Break It Up: A Study Evaluating Breaking Up Daily Sedentary Behavior in Youth Completed
  40. Phase 2 A Study to Evaluate the Change in Weight After 24 Weeks Treatment With LIK066 in Obese or Overweight Adults Completed
  41. Phase 2 A Study to Evaluate the Effect on Body Weight of Leptin Administered in Conjunction With Pramlintide in Overweight and Obese Subjects Completed
  42. Phase 2 Inflammation, Polyphenols, and Genetics Completed
  43. Phase 2 A Study to Evaluate How VI-0521 Affect Psychomotor Performance in Healthy Overweight and Obese Subjects. Completed
  44. Phase 2 Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity. Completed

Showing the 50 most-cited and recently-updated of 140 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Overweight

Did extending sleep duration change insulin sensitivity in people with overweight?

No, extending sleep by about 1 hour per night for 6 weeks did not change insulin sensitivity in people with overweight or obesity who were short sleepers.

Full answer →
Do wholegrain rye diets help with weight loss in overweight adults?

Wholegrain rye diets do not lead to significantly more weight loss than refined wheat diets in overweight adults, but they improve metabolic markers like inflammation and gut health.

Full answer →
Do stand-alone digital lifestyle interventions improve weight for adults with overweight?

Yes, stand-alone digital lifestyle interventions (fully automated apps or websites) lead to modest weight loss and improved dietary habits in adults with overweight or obesity, based on a 2026 meta-analysis.

Full answer →
How does tirzepatide compare to semaglutide for weight reduction in adults without diabetes?

Tirzepatide leads to greater weight loss than semaglutide in adults without diabetes, based on network meta-analyses and cohort studies.

Full answer →

All Overweight Articles